BATS BZX Real-Time Price
As of 11:04am ET
| +3.40 / +3.42%|
The 6 analysts offering 12-month price forecasts for Synageva BioPharma Corp have a median target of 115.50, with a high estimate of 125.00 and a low estimate of 111.00. The median estimate represents a +12.33% increase from the last price of 102.82.
The current consensus among 6 polled investment analysts is to Buy stock in Synageva BioPharma Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.